Early access to SL-28 for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This trial provides early access to an experimental drug called SL-28 for people with advanced solid tumors that have not responded to or have come back after standard treatments. The goal is to see if the drug can help control the cancer when other options have run out.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a solid tumor that has spread to nearby tissue or other parts of the body, or cannot be removed with surgery.
- Your cancer must have grown or come back after at least one standard treatment.
- You need to be generally able to care for yourself (performance status 0-3) and expected to live more than 12 weeks.
- Your bone marrow and major organs must be working well enough to handle the treatment.
- You must have had a break from certain treatments before starting: at least 60 days from radiation, 42 days from immunotherapy, and 7 days from growth factor injections.
- If you are of childbearing age (man or woman), you must agree to use highly effective birth control or abstain from sex during the study and for one week after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, SL-28, for people with advanced solid tumors that haven’t responded to or cannot be treated with standard therapies. It aims to find a safe dose and see if the drug can help shrink or slow the growth of your cancer.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This trial tests a new drug that may help people with advanced solid tumors that have not responded to other treatments. The drug is given as an injection and aims to stop cancer growth.
This trial tests a new drug called NBL-028 in people with advanced solid tumors that have a specific protein (CLDN6). It is for those who have already tried standard treatments. The goal is to see how safe and effective the drug is.
This trial tests an experimental drug called CS231295 for people with advanced solid tumors that have not responded to standard treatments. The purpose is to study safety and find out if the drug can shrink tumors.
This phase 1 trial tests a new drug called SLV-324 for people with solid tumors that have spread and are no longer responding to standard treatments. The goal is to see if the drug is safe and works against the cancer.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.